StockStory.org on MSN

5 Insightful Analyst Questions From Vertex Pharmaceuticals’s Q3 Earnings Call

Vertex Pharmaceuticals’ third quarter was marked by steady double-digit revenue growth, yet the market responded negatively ...
Digital Camera World on MSN

I used Nikon’s Focus Shift Shooting for the first time – here’s why I’ll think twice before focus stacking manually again

Make focus stacking a breeze by automating the process using your Nikon camera’s Focus Shift Shooting function ...

The Power Of Precision: Why Focus Beats Options During A Career Pivot

If you lead with your subject matter expertise and know who can benefit from your skills, you will market yourself ...
BioSpace

Novartis, Vertex, More Optimizing Shots on Multiple Goals in Lucrative I&I Space

With immunology and inflammation blockbusters like AbbVie’s Skyrizi and Rinvoq reeling in nearly $7 billion combined in the ...

Vertex Pharmaceuticals Incorporated (VRTX) Presents at UBS Global Healthcare Conference 2025 Transcript

Good morning, everyone. My name is Dina Elmonshed, one of the U.S. biotech analysts here at UBS. And joining me today is the President and CEO of Vertex Pharmaceuticals, Reshma Kewalramani. Thank you ...